英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字,中文词皆可:


请选择你想看的字典辞典:
单词字典翻译
kindleth查看 kindleth 在百度字典中的解释百度英翻中〔查看〕
kindleth查看 kindleth 在Google字典中的解释Google英翻中〔查看〕
kindleth查看 kindleth 在Yahoo字典中的解释Yahoo英翻中〔查看〕





安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Home - Alterome
    Alterome is a clinical-stage precision oncology company developing first-in-class, alteration-specific therapies for AKT E17K- and KRAS-driven cancers
  • About - Alterome
    Transforming how cancer is treated Discovering and developing medicines targeting the world’s deadliest cancers The alterome, defined as all disease-driving genetic alterations, remains largely unaddressed by current therapies While targeted therapies have brought meaningful progress to patients, many aggressive cancers lack effective treatment options Available therapies often cause
  • News - Alterome
    Alterome Therapeutics, Inc , a clinical stage biopharmaceutical company pioneering the development of next generation, small molecule targeted therapies for the treatment of cancer, today announced the dosing of the first patient in AKTive-001, a Phase 1 1b trial of ALTA2618 in adults with AKT1 E17K-mutant advanced solid tumors
  • Pipeline - Alterome
    Advancing medicines designed to change the treatment paradigm Developing alteration-specific therapies that cancers can’t evade We are advancing a pipeline of next-generation, small molecule targeted therapies across a range of cancers Target Indication Discovery preclinical IND Enabling Phase 1 1B AKT1 E17K (ALTA2618) Phase 1 1B Breast and endometrial cancers, solid tumors KRAS selective
  • Careers - Alterome
    Alterome Therapeutics, Inc is an equal opportunity employer committed to building a diverse and inclusive organization We measure each applicant, candidate, and employee based on their qualifications for the role, regardless of age, sex, religion, sexual orientation, gender identity, national origin, Veteran status, disability, and or any
  • Alterome Doses First Patient in Phase 1 Study of ALTA3263, a Novel Pan . . .
    Alterome Therapeutics, Inc , a clinical-stage biopharmaceutical company pioneering the development of next-generation, small molecule targeted therapies for the treatment of cancer, today announced that the first patient has been dosed in the Phase 1 1b trial of ALTA3263 in adults with KRAS mutant solid tumors
  • News Archives - Page 3 of 3 - Alterome
    Alterome Therapeutics 13480 Evening Creek Drive North Suite 450 San Diego, CA 92128 General information info@alterome com Clinical trials clinical trials@alterome com
  • Science - Alterome
    Shifting expectations WITH OUR BOLD APPROACH Tackling cancer’s most wanted targets with bold science and deep expertise Our team brings decades of experience in targeted oncology drug development, with a unique blend of expertise in computational and quantum chemistry, medicinal chemistry, and translational biology We excel at rapidly applying next-generation drug discovery technologies to
  • News Archives - Page 2 of 3 - Alterome
    Alterome Therapeutics 13480 Evening Creek Drive North Suite 450 San Diego, CA 92128
  • Alterome raises $132M to take next-gen cancer drugs aimed at the . . .
    With a new $132 million in hand, Alterome Therapeutics is finally divulging what it’s working on The oncology company will be using its Series B raise to bring two programs — each designed to go after specific cancer-driving mutations — to the clinic within the next year





中文字典-英文字典  2005-2009